The European Commission’s proposals on endocrine disruptors have provoked strong reactions among both stakeholders and member states. The divisions are clear, including within the Council where some member states, such as Sweden, Denmark and France, want tougher rules while others, like the United Kingdom, are calling for potency to be among the criteria.
In mid-June, the Commission proposed using the definition in the World Health Organisation’s international programme on chemical...